Moderna’s coronavirus vaccine is 94.1% effective in preventing COVID-19 and 100% effective in preventing severe illness, according to final results announced by the company on Monday (Nov. 30).
The drugmaker Moderna said on Wednesday that it would soon begin testing its coronavirus vaccine in children ages 12 through 17. The study, listed Wednesday on the website… Read More
You might assume that 95 out of every 100 people vaccinated will be protected from Covid-19. But that’s not how the math works. Read More
With Pfizer and Moderna both releasing promising interim clinical data in the past two weeks, the world is getting one step closer to having a Covid-19 vaccine on the market, but… Read More
Does this mean the end of the pandemic? Who was in the trial? Is it part of Operation Warp Speed? And other questions answered. Read More
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be…
Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation. Read More
Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups Read More
Each year, the flu vaccine has to be redesigned to account for mutations that the virus accumulates, and even then, the vaccine is often not fully protective… Read More
Two vaccine trials are on hold in the US, and two are underway Read More
